Responsible Artificial Intelligence governance in oncology

Responsible Artificial Intelligence governance in oncology

The use of Artificial Intelligence (AI) in healthcare is expanding rapidly, including in oncology. Although generic AI development and implementation frameworks exist in healthcare, no effective governance models have been reported in oncology. Our study reports on a Comprehensive Cancer Center’s Responsible AI governance model for clinical, operations, and research programs. We report our one-year AI Governance Committee results with respect to…

At ASCO, Testing and AI Rival Drugs for Attention, but Reimbursement Remains a Barrier

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage cancer care over time. A feature from our upcoming special issue of Evidence-Based Oncology: our annual ASCO recap.

Artificial Intelligence (AI) in Precision Medicine Market to Show Strong Growth | Google Health, Roche, PathAI

Open the article to view the coverage from Newstrail.com